Advertisement
Screener

Merck & Co., Inc. (MRK) Net Income (Loss) Attributable to Noncontrolling Interest

2.2 / 5 stars · 50/112 Roast Me

Merck & Co., Inc. Net Income (Loss) Attributable to Noncontrolling Interest

Merck & Co., Inc. (MRK) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-07

  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$2.00M, a 300.00% decline year-over-year.
  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$3.00M, a 150.00% decline year-over-year.
  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.00M, a 200.00% decline year-over-year.
  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $2.00M, a 50.00% decline year-over-year.
  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $9.00M, a 43.75% decline from fiscal 2024.
  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $16.00M, a 33.33% increase from fiscal 2023.
  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $12.00M, a 71.43% increase from fiscal 2022.
  • Merck & Co., Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $7.00M, a 56.25% decline from fiscal 2021.
Period endNet Income (Loss) Attributable to Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 12 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30-$2.00M
10-Q · filed 2026-08-07
-$5.00M
10-Q · filed 2026-08-07
-$6.00M
derived: sum of 3 quarters · filed 2026-08-07
-$4.00M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$3.00M
10-Q · filed 2026-05-04
-$4.00M
derived: sum of 2 quarters · filed 2026-05-04
-$2.00M
derived: sum of 3 quarters · filed 2026-05-04
-$1.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$1.00M
derived: sum of 2 quarters · filed 2026-02-24
$2.00M
derived: sum of 3 quarters · filed 2026-08-07
$9.00M
10-K · filed 2026-02-24
2025-09-30$2.00M
10-Q · filed 2025-11-05
$3.00M
derived: sum of 2 quarters · filed 2026-08-07
$10.00M
10-Q · filed 2025-11-05
$10.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$1.00M
10-Q · filed 2026-08-07
$8.00M
10-Q · filed 2026-08-07
$8.00M
derived: sum of 3 quarters · filed 2026-08-07
$12.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$6.00M
10-Q · filed 2026-05-04
$7.00M
derived: sum of 2 quarters · filed 2026-05-04
$11.00M
derived: sum of 3 quarters · filed 2026-05-04
$17.00M
derived: sum of 4 quarters · filed 2026-05-04
2024-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$5.00M
derived: sum of 2 quarters · filed 2026-02-24
$11.00M
derived: sum of 3 quarters · filed 2026-02-24
$16.00M
10-K · filed 2026-02-24
2024-09-30$4.00M
10-Q · filed 2025-11-05
$10.00M
derived: sum of 2 quarters · filed 2025-11-05
$15.00M
10-Q · filed 2025-11-05
$15.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$6.00M
10-Q · filed 2025-08-05
$11.00M
10-Q · filed 2025-08-05
$11.00M
derived: sum of 3 quarters · filed 2026-02-24
$16.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$5.00M
10-Q · filed 2025-05-02
$5.00M
derived: sum of 2 quarters · filed 2026-02-24
$10.00M
derived: sum of 3 quarters · filed 2026-02-24
$13.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$5.00M
derived: sum of 2 quarters · filed 2026-02-24
$8.00M
derived: sum of 3 quarters · filed 2026-02-24
$12.00M
10-K · filed 2026-02-24
2023-09-30$5.00M
10-Q · filed 2024-11-06
$8.00M
derived: sum of 2 quarters · filed 2024-11-06
$12.00M
10-Q · filed 2024-11-06
$13.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$3.00M
10-Q · filed 2024-08-05
$7.00M
10-Q · filed 2024-08-05
$8.00M
derived: sum of 3 quarters · filed 2025-02-25
$13.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$4.00M
10-Q · filed 2024-05-03
-$4.00M
10-Q · filed 2023-05-05
$5.00M
derived: sum of 2 quarters · filed 2025-02-25
$10.00M
derived: sum of 3 quarters · filed 2025-02-25
$15.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$6.00M
derived: sum of 2 quarters · filed 2025-02-25
$11.00M
derived: sum of 3 quarters · filed 2025-02-25
$7.00M
10-K · filed 2025-02-25
2022-09-30$5.00M
10-Q · filed 2023-11-03
$10.00M
derived: sum of 2 quarters · filed 2023-11-03
$6.00M
10-Q · filed 2023-11-03
$17.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30$5.00M
10-Q · filed 2023-08-07
$2.00M
10-Q · filed 2023-08-07
$12.00M
derived: sum of 3 quarters · filed 2024-02-26
$16.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31$3.00M
10-Q · filed 2023-05-05
-$3.00M
10-Q · filed 2022-05-05
$7.00M
derived: sum of 2 quarters · filed 2024-02-26
$11.00M
derived: sum of 3 quarters · filed 2024-02-26
$12.00M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$8.00M
derived: sum of 2 quarters · filed 2024-02-26
$9.00M
derived: sum of 3 quarters · filed 2024-02-26
$16.00M
10-K · filed 2024-02-26
2021-09-30$4.00M
10-Q · filed 2022-11-03
$5.00M
derived: sum of 2 quarters · filed 2022-11-03
$12.00M
10-Q · filed 2022-11-03
$15.00M
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30$1.00M
10-Q · filed 2022-08-05
$8.00M
10-Q · filed 2022-08-05
$11.00M
derived: sum of 3 quarters · filed 2023-02-24
$15.00M
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31$7.00M
10-Q · filed 2022-05-05
$10.00M
derived: sum of 2 quarters · filed 2023-02-24
$14.00M
derived: sum of 3 quarters · filed 2023-02-24
$22.00M
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$7.00M
derived: sum of 2 quarters · filed 2023-02-24
$15.00M
derived: sum of 3 quarters · filed 2023-02-24
$15.00M
10-K · filed 2023-02-24
2020-09-30$4.00M
10-Q · filed 2021-11-05
$12.00M
derived: sum of 2 quarters · filed 2021-11-05
$12.00M
10-Q · filed 2021-11-05
$19.00M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$8.00M
10-Q · filed 2021-08-09
$8.00M
10-Q · filed 2021-08-09
$15.00M
derived: sum of 3 quarters · filed 2022-02-25
$21.00M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$0.00
10-Q · filed 2021-05-05
$7.00M
derived: sum of 2 quarters · filed 2022-02-25
$13.00M
derived: sum of 3 quarters · filed 2022-02-25
-$13.00M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$13.00M
derived: sum of 2 quarters · filed 2022-02-25
-$13.00M
derived: sum of 3 quarters · filed 2022-02-25
-$66.00M
10-K · filed 2022-02-25
2019-09-30$6.00M
10-Q · filed 2020-11-05
-$20.00M
derived: sum of 2 quarters · filed 2020-11-05
-$73.00M
10-Q · filed 2020-11-05
-$122.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$26.00M
10-Q · filed 2020-08-05
-$79.00M
10-Q · filed 2020-08-05
-$128.00M
derived: sum of 3 quarters · filed 2021-02-25
-$120.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$53.00M
10-Q · filed 2020-05-06
-$102.00M
derived: sum of 2 quarters · filed 2021-02-25
-$94.00M
derived: sum of 3 quarters · filed 2021-02-25
-$85.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$49.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$41.00M
derived: sum of 2 quarters · filed 2021-02-25
-$32.00M
derived: sum of 3 quarters · filed 2021-02-25
-$27.00M
10-K · filed 2021-02-25
2018-09-30$8.00M
10-Q · filed 2019-11-05
$17.00M
derived: sum of 2 quarters · filed 2019-11-05
$22.00M
10-Q · filed 2019-11-05
$30.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$9.00M
10-Q · filed 2019-08-06
$14.00M
10-Q · filed 2019-08-06
$22.00M
derived: sum of 3 quarters · filed 2020-02-26
$27.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$5.00M
10-Q · filed 2019-05-08
$13.00M
derived: sum of 2 quarters · filed 2020-02-26
$18.00M
derived: sum of 3 quarters · filed 2020-02-26
$23.00M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$13.00M
derived: sum of 2 quarters · filed 2020-02-26
$18.00M
derived: sum of 3 quarters · filed 2020-02-26
$24.00M
10-K · filed 2020-02-26
2017-09-30$5.00M
10-Q · filed 2018-11-06
$10.00M
derived: sum of 2 quarters · filed 2018-11-06
$16.00M
10-Q · filed 2018-11-06
$23.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$5.00M
10-Q · filed 2018-08-07
$11.00M
10-Q · filed 2018-08-07
$18.00M
derived: sum of 3 quarters · filed 2019-02-27
$22.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$5.00M
10-Q · filed 2018-05-08
$13.00M
derived: sum of 2 quarters · filed 2019-02-27
$17.00M
derived: sum of 3 quarters · filed 2019-02-27
$21.00M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$12.00M
derived: sum of 2 quarters · filed 2019-02-27
$16.00M
derived: sum of 3 quarters · filed 2019-02-27
$21.00M
10-K · filed 2019-02-27
2016-09-30$4.00M
10-Q · filed 2017-11-07
$8.00M
derived: sum of 2 quarters · filed 2017-11-07
$13.00M
10-Q · filed 2017-11-07
$18.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$4.00M
10-Q · filed 2017-08-08
$9.00M
10-Q · filed 2017-08-08
$14.00M
derived: sum of 3 quarters · filed 2018-02-27
$19.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$5.00M
10-Q · filed 2017-05-09
$10.00M
derived: sum of 2 quarters · filed 2018-02-27
$15.00M
derived: sum of 3 quarters · filed 2018-02-27
$16.00M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$10.00M
derived: sum of 2 quarters · filed 2018-02-27
$11.00M
derived: sum of 3 quarters · filed 2018-02-27
$17.00M
10-K · filed 2018-02-27
2015-09-30$5.00M
10-Q · filed 2016-11-07
$6.00M
derived: sum of 2 quarters · filed 2016-11-07
$12.00M
10-Q · filed 2016-11-07
$22.00M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$1.00M
10-Q · filed 2016-08-08
$7.00M
10-Q · filed 2016-08-08
$17.00M
derived: sum of 3 quarters · filed 2017-02-28
-$36.00M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$5.00M
10-Q · filed 2016-05-09
$16.00M
derived: sum of 2 quarters · filed 2017-02-28
-$37.00M
derived: sum of 3 quarters · filed 2017-02-28
-$8.00M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$11.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$42.00M
derived: sum of 2 quarters · filed 2017-02-28
-$13.00M
derived: sum of 3 quarters · filed 2017-02-28
$14.00M
10-K · filed 2017-02-28
2014-09-30-$53.00M
10-Q · filed 2015-11-05
-$24.00M
derived: sum of 2 quarters · filed 2015-11-05
$3.00M
10-Q · filed 2015-11-05
$36.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$29.00M
10-Q · filed 2015-08-06
$55.00M
10-Q · filed 2015-08-06
$89.00M
derived: sum of 3 quarters · filed 2016-02-26
$115.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$26.00M
10-Q · filed 2015-05-07
$60.00M
derived: sum of 2 quarters · filed 2016-02-26
$86.00M
derived: sum of 3 quarters · filed 2016-02-26
$115.00M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$34.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$60.00M
derived: sum of 2 quarters · filed 2016-02-26
$89.00M
derived: sum of 3 quarters · filed 2016-02-26
$113.00M
10-K · filed 2016-02-26
2013-09-30$26.00M
10-Q · filed 2014-11-10
$55.00M
derived: sum of 2 quarters · filed 2014-11-10
$79.00M
10-Q · filed 2014-11-10
$120.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$29.00M
10-Q · filed 2014-08-07
$52.00M
10-Q · filed 2014-08-07
$94.00M
derived: sum of 3 quarters · filed 2015-02-27
$128.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$23.00M
10-Q · filed 2014-05-08
$65.00M
derived: sum of 2 quarters · filed 2015-02-27
$99.00M
derived: sum of 3 quarters · filed 2015-02-27
$126.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$42.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$76.00M
derived: sum of 2 quarters · filed 2015-02-27
$103.00M
derived: sum of 3 quarters · filed 2015-02-27
$131.00M
10-K · filed 2015-02-27
2012-09-30$34.00M
10-Q · filed 2013-11-07
$61.00M
derived: sum of 2 quarters · filed 2013-11-07
$89.00M
10-Q · filed 2013-11-07
$121.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$27.00M
10-Q · filed 2013-08-07
$56.00M
10-Q · filed 2013-08-07
$87.00M
derived: sum of 3 quarters · filed 2014-02-27
$119.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$29.00M
10-Q · filed 2013-05-09
$60.00M
derived: sum of 2 quarters · filed 2014-02-27
$92.00M
derived: sum of 3 quarters · filed 2014-02-27
$122.00M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31$31.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
$63.00M
derived: sum of 2 quarters · filed 2014-02-27
$93.00M
derived: sum of 3 quarters · filed 2014-02-27
$120.00M
10-K · filed 2014-02-27
2011-09-30$32.00M
10-Q · filed 2012-11-09
$62.00M
derived: sum of 2 quarters · filed 2012-11-09
$89.00M
10-Q · filed 2012-11-09
$122.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$30.00M
10-Q · filed 2012-08-07
$58.00M
10-Q · filed 2012-08-07
$90.00M
derived: sum of 3 quarters · filed 2013-02-28
$120.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$28.00M
10-Q · filed 2012-05-08
$60.00M
derived: sum of 2 quarters · filed 2013-02-28
$90.00M
derived: sum of 3 quarters · filed 2013-02-28
$118.00M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$62.00M
derived: sum of 2 quarters · filed 2013-02-28
$90.00M
derived: sum of 3 quarters · filed 2013-02-28
$121.00M
10-K · filed 2013-02-28
2010-09-30$30.00M
10-Q · filed 2011-11-08
$30.10M
10-Q · filed 2010-11-08
$58.00M
derived: sum of 2 quarters · filed 2011-11-08
$89.00M
10-Q · filed 2011-11-08
$89.30M
10-Q · filed 2010-11-08
$118.20M
derived: sum of 4 quarters · filed 2012-02-28
2010-06-30$28.00M
10-Q · filed 2011-08-08
$27.80M
10-Q · filed 2010-08-06
$59.00M
10-Q · filed 2011-08-08
$59.20M
10-Q · filed 2010-08-06
$88.20M
derived: sum of 3 quarters · filed 2012-02-28
$119.20M
derived: sum of 4 quarters · filed 2012-02-28
2010-03-31$31.00M
10-Q · filed 2011-05-09
$31.40M
10-Q · filed 2010-05-07
$60.20M
derived: sum of 2 quarters · filed 2012-02-28
$91.20M
derived: sum of 3 quarters · filed 2012-02-28
$123.20M
derived: sum of 4 quarters · filed 2012-02-28
2009-12-31$29.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$60.20M
derived: sum of 2 quarters · filed 2012-02-28
$92.20M
derived: sum of 3 quarters · filed 2012-02-28
$123.00M
10-K · filed 2012-02-28
$122.90M
10-K · filed 2010-03-01
2009-09-30$31.00M
10-Q · filed 2010-11-08
$63.00M
derived: sum of 2 quarters · filed 2010-11-08
$93.80M
10-Q · filed 2010-11-08
2009-06-30$32.00M
10-Q · filed 2010-08-06
$62.80M
10-Q · filed 2010-08-06
2009-03-31$30.80M
10-Q · filed 2010-05-07
2008-12-31$124.00M
10-K · filed 2011-02-28
$123.90M
10-K · filed 2010-03-01
2007-12-31$121.40M
10-K · filed 2010-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60